ACE inhibition after myocardial infarction: can megatrials provide answers?
- 15 October 1994
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 344 (8929) , 1068-1069
- https://doi.org/10.1016/s0140-6736(94)91717-5
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.Circulation, 1994
- Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.Circulation, 1993
- Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors.Circulation, 1993
- β-Blockers after Myocardial Infarction: Influence of First-Year Clinical Course on Long-Term EffectivenessAnnals of Internal Medicine, 1993
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992